Back to
Renaissance Technologies LLC
MCRB
17 quarters
Position history for
Renaissance Technologies LLC's holdings in Seres Therapeutics, Inc.
No. Renaissance Technologies exited its MCRB (Seres Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 817,000 shares worth $1.1M. Renaissance Technologies already held MCRB in its Q3 2019 13F, the earliest on record, and held it in 14 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$4.3M
Total Shares Change
-1.1M
Quarter-by-Quarter History
Other major holders of MCRB: ARK Investment Management LLC, FMR LLC